Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cencora, Inc. (COR : NYSE)
 
 • Company Description   
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

Number of Employees: 46,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $295.21 Daily Weekly Monthly
20 Day Moving Average: 1,247,244 shares
Shares Outstanding: 193.82 (millions)
Market Capitalization: $57,218.63 (millions)
Beta: 0.57
52 Week High: $309.35
52 Week Low: $218.65
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.11% -4.62%
12 Week 2.95% -13.12%
Year To Date 31.39% 23.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 West First Avenue
-
Conshohocken,PA 19428
USA
ph: 610-727-7000
fax: 800-640-5221
investorrelations@cencora.com http://www.cencora.com
 
 • General Corporate Information   
Officers
Robert P. Mauch - Chief Executive Officer;President and Director
Steven H. Collis - Executive Chairman of the Board
James F. Cleary - Chief Financial Officer and Executive Vice Preside
Lazarus Krikorian - Senior Vice President and Chief Accounting Officer
D. Mark Durcan - Director

Peer Information
Cencora, Inc. (CHCR)
Cencora, Inc. (ESRX)
Cencora, Inc. (MYDP)
Cencora, Inc. (COR)
Cencora, Inc. (GBCS)
Cencora, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03073E105
SIC: 5122
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 193.82
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.57
Market Capitalization: $57,218.63 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.75%
Current Fiscal Quarter EPS Consensus Estimate: $3.84 Indicated Annual Dividend: $2.20
Current Fiscal Year EPS Consensus Estimate: $15.81 Payout Ratio: 0.15
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: -0.03
Estmated Long-Term EPS Growth Rate: 12.77% Last Dividend Paid: 05/16/2025 - $0.55
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.67
Trailing 12 Months: 19.91
PEG Ratio: 1.46
Price Ratios
Price/Book: 48.49
Price/Cash Flow: 14.85
Price / Sales: 0.18
EPS Growth
vs. Year Ago Period: 16.32%
vs. Previous Quarter: 18.50%
Sales Growth
vs. Year Ago Period: 10.29%
vs. Previous Quarter: -7.40%
ROE
06/30/25 - -
03/31/25 - 344.71
12/31/24 - 328.62
ROA
06/30/25 - -
03/31/25 - 4.26
12/31/24 - 4.23
Current Ratio
06/30/25 - -
03/31/25 - 0.87
12/31/24 - 0.92
Quick Ratio
06/30/25 - -
03/31/25 - 0.52
12/31/24 - 0.54
Operating Margin
06/30/25 - -
03/31/25 - 0.94
12/31/24 - 0.93
Net Margin
06/30/25 - -
03/31/25 - 0.55
12/31/24 - 0.46
Pre-Tax Margin
06/30/25 - -
03/31/25 - 0.74
12/31/24 - 0.61
Book Value
06/30/25 - -
03/31/25 - 6.09
12/31/24 - 1.87
Inventory Turnover
06/30/25 - -
03/31/25 - 15.61
12/31/24 - 15.55
Debt-to-Equity
06/30/25 - -
03/31/25 - 6.01
12/31/24 - 16.40
Debt-to-Capital
06/30/25 - -
03/31/25 - 85.73
12/31/24 - 94.25
 

Powered by Zacks Investment Research ©